Related Experiment Video
Updated: Jun 4, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective
Toshinori Totsugawa1, Masahiko Kuinose, Hidenori Yoshitaka
1Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, 2-1-10 Marunouchi, Okayama 700-0823, Japan. toshinoritotsugawa@mac.com
Purpose:
Endotoxin adsorption treatment (direct hemoperfusion using a polymyxin-B immobilized fiber column, or PMX-DHP) is now considered a useful option for treating severe sepsis. However, the efficacy of PMX-DHP for infective endocarditis (IE), in which the causative microorganisms are usually gram-positive cocci, remains unclear. In the present study, we investigated the impact of intraoperative PMX-DHP on clinical parameters during the treatment of IE.
Methods:
From November 2006 to December 2009, a total of 11 patients with active IE underwent emergent surgery using intraoperative PMX-DHP. The perioperative courses of these patients were compared with those of seven patients who underwent emergent surgery for active IE with the conventional method from January 2003 to October 2006.
Results:
PMX-DHP was associated with a significant decrease in the postoperative catecholamine dose and duration. Intubation time and intensive care unit length of stay for the PMX-DHP group was significantly shorter than that for the conventional therapy group. There was also a significant difference in the number of failed organs postoperatively between the two groups.
Conclusion:
Intraoperative PMX-DHP demonstrated several positive effects, such as a drastic decrease in the doses of inotropic agents and shortening of the duration of mechanical ventilation, in patients who underwent emergent surgery for active IE. Intraoperative PMX-DHP can be a useful option for the treatment of critically ill patients with IE.
Insights
Intraoperative polymyxin-B hemoperfusion (PMX-DHP) significantly improved outcomes for patients undergoing surgery for infective endocarditis (IE). This endotoxin adsorption therapy reduced the need for inotropic agents and shortened recovery times.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Endotoxin adsorption therapy, specifically polymyxin-B direct hemoperfusion (PMX-DHP), is established for severe sepsis.
- The effectiveness of PMX-DHP in infective endocarditis (IE), often caused by gram-positive bacteria, is not well-defined.
Purpose of the Study:
- To evaluate the impact of intraoperative PMX-DHP on clinical outcomes in patients with active IE undergoing emergent surgery.
Main Methods:
- A comparative study of 11 patients receiving intraoperative PMX-DHP during IE surgery (2006-2009) versus 7 patients treated conventionally (2003-2006).
Main Results:
- PMX-DHP group showed significantly reduced postoperative catecholamine requirements and shorter intubation and ICU stays.
- A notable difference in the number of postoperative organ failures was observed between the groups.
Conclusions:
- Intraoperative PMX-DHP offers benefits for emergent IE surgery, including reduced inotropic agent use and mechanical ventilation duration.
- PMX-DHP is a potentially valuable treatment option for critically ill IE patients.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiomyopathy V: Interprofessional Care
